Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1992 2
1994 1
1996 1
1997 2
1998 1
1999 3
2000 2
2002 1
2005 1
2006 3
2007 1
2008 4
2009 5
2010 6
2011 2
2013 4
2014 3
2015 4
2016 3
2017 3
2018 3
2020 1
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Duong VH, Ruppert AS, Mims AS, Borate U, Stein EM, Baer MR, Stock W, Kovacsovics T, Blum W, Arellano ML, Schiller GJ, Olin RL, Foran JM, Litzow MR, Lin TL, Patel PA, Foster MC, Redner RL, Al-Mansour Z, Cogle CR, Swords RT, Collins RH, Vergilio JA, Heerema NA, Rosenberg L, Yocum AO, Marcus S, Chen T, Druggan F, Stefanos M, Gana TJ, Shoben AB, Druker BJ, Burd A, Byrd JC, Levine RL, Boyiadzis MM. Duong VH, et al. Among authors: redner rl. Cancer. 2023 Aug 1;129(15):2308-2320. doi: 10.1002/cncr.34780. Epub 2023 Apr 20. Cancer. 2023. PMID: 37078412 Clinical Trial.
STAT transcription factors in normal and cancer stem cells.
Dorritie KA, Redner RL, Johnson DE. Dorritie KA, et al. Among authors: redner rl. Adv Biol Regul. 2014 Sep;56:30-44. doi: 10.1016/j.jbior.2014.05.004. Epub 2014 Jun 5. Adv Biol Regul. 2014. PMID: 24931719 Review.
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Lontos K, Tsagianni A, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Aggarwal N, Saul M, Boyiadzis M, Bailey NG. Lontos K, et al. Among authors: redner rl. Leuk Lymphoma. 2023 Mar;64(3):750-752. doi: 10.1080/10428194.2023.2172981. Epub 2023 Feb 1. Leuk Lymphoma. 2023. PMID: 36722791 Free PMC article. No abstract available.
The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
Swaney EM, Chattopadhyay A, Abecassis I, Rush EA, Redner RL. Swaney EM, et al. Among authors: redner rl. Leuk Lymphoma. 2016 Aug;57(8):1933-7. doi: 10.3109/10428194.2015.1124992. Epub 2016 Jan 12. Leuk Lymphoma. 2016. PMID: 26754533 Free PMC article.
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Lontos K, Tsagianni A, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Aggarwal N, Saul M, Gooding W, Boyiadzis M. Lontos K, et al. Among authors: redner rl. Leuk Lymphoma. 2022 Dec;63(13):3257-3260. doi: 10.1080/10428194.2022.2118532. Epub 2022 Sep 8. Leuk Lymphoma. 2022. PMID: 36075047 Free PMC article. No abstract available.
58 results